Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
TORNTPHARM Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and stable ROE
High and stable operating margin
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low revenue growth and in line with median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
TORNTPHARM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
TORNTPHARM Bulk, Block & Insider Trades
TORNTPHARM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Others
Bonus(1 new shares for 1 existing shares) Ex-date: 8th Jul 2022 Announced on: 25th May 2022
Bonus(1 new shares for 1 existing shares) Ex-date: 23rd Jul 2013 Announced on: 30th May 2013
Complex capital changeNominal Value has been changed from Rs 10 to Rs 5. Bonus issue of 42319680 securities. Ex-date: 20th Feb 2006 Announced on: 15th Dec 2005
Company Profile
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments... Read More
Key personnel
Shri. Samir MehtaD
Executive Chairman of the Board
Shri. Sudhir MehtaD
Chairman Emeritus
Shri. Sudhir Menon
Chief Financial Officer, Executive Director - Finance
Mr. Chintan M. Trivedi
Compliance Officer, Company Secretary
Mr. Aman MehtaD
Managing Director, Whole-Time Director
Mr. Jinal MehtaD
Non-Executive Non-Independent Director
Ms. Nayantara BaliD
Independent Director
Mr. Manish ChoksiD
Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Torrent Pharmaceuticals Ltd.?
The current share price of Torrent Pharmaceuticals Ltd. is ₹ 3,963.13 as of 09 Jan 2026.
What is the PE ratio of Torrent Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Torrent Pharmaceuticals Ltd. is 62.67 as of the latest financial data.
What is the ROE and ROCE of Torrent Pharmaceuticals Ltd.?
Torrent Pharmaceuticals Ltd. has a Return on Equity (ROE) of 26.83% and a Return on Capital Employed (ROCE) of 29.11% as per the latest financial reports.
What is the market cap of Torrent Pharmaceuticals Ltd.?
The market capitalization of Torrent Pharmaceuticals Ltd. stands at ₹ 1,34,130.00 Cr.
What is the dividend yield of Torrent Pharmaceuticals Ltd.?
The dividend yield of Torrent Pharmaceuticals Ltd. is 0.81% based on the current market price.
What is the RSI of Torrent Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Torrent Pharmaceuticals Ltd. is 61.70.
What is the FII and DII holding in Torrent Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 16.13% and Domestic Institutional Investors (DII) hold 6.55% of Torrent Pharmaceuticals Ltd. shares.
What sector does Torrent Pharmaceuticals Ltd. belong to?
Torrent Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Torrent Pharmaceuticals Ltd. stock?
The beta of Torrent Pharmaceuticals Ltd. stock is 0.56, indicating its volatility relative to the broader market.
